Luo, Yan
Pandey, Ankur
Ghasabeh, Mounes Aliyari
Pandey, Pallavi
Varzaneh, Farnaz Najmi
Zarghampour, Manijeh
Khoshpouri, Pegah
Ameli, Sanaz
Li, Zhen
Hu, Daoyu
Kamel, Ihab R.
Article History
Received: 17 September 2018
Revised: 31 January 2019
Accepted: 11 February 2019
First Online: 15 March 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Ihab R Kamel.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in a previously published paper (Gowdra HV et al Neuroendocrine liver metastasis treated by using intra-arterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology 2013; 266:502–513). We have reported on 55 out of 84 patients included in the current study. However, the prior report focused on the prognostic value of pre- and post-TACE changes in volumetric multiparametric MR imaging of the dominant lesion for predicting overall survival. The current study included a larger sample size and evaluated whether baseline volumetric MR imaging only can predict overall survival and hepatic progression-free survival. Also, the prognostic values of baseline volumetric MR metrics using three different numbers of index lesions (one, two, and five) were compared in the current study.
: • retrospective• diagnostic or prognostic study• performed at one institution